Home
About
Overview
Management Team
Board of Directors
Technology
Overview
Posters
Pipeline
Overview
MT-3724
MT-5111
TAK-169
Clinical Trials
Overview
MT-3724 With Lenalidomide for Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Active, not recruiting
MT-3724 for Relapsed or Refractory DLBCL
Active, not recruiting
MT-3724 With Gemcitabine and Oxaliplatin for Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Active, not recruiting
MT-5111 in HER2-positive Solid Tumors
Recruiting
TAK-169 for Relapsed or Refractory Multiple Myeloma (RRMM)
Recruiting
News & Media
Press Releases
Presentations
Events
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Email Alerts
Contact
Careers
Posters
Technology
Technology
Overview
Posters
2021 AACR – MT-5111
2021 AACR – MT-6402
2021 AACR – CTLA-4
2020 EHA - MT-3724 Monotherapy Poster - June 2020
2020 EHA - MT-3724 Len Poster - June 2020
2020 AACR - SLAMF7 Poster - April 2020
2020 AACR - MT-6402 Poster - April 2020
2020 AACR - CTLA-4 Poster - April 2020
2020 AACR - CD45 poster - April 2020
2020 ASCO GI - MT-5111 Preclinical Poster - January 2020
